BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35332045)

  • 21. Interventions to improve human papillomavirus vaccination among Chinese female college students: study protocol for a randomized controlled trial.
    Si M; Su X; Jiang Y; Qiao Y; Liu Y
    BMC Public Health; 2019 Nov; 19(1):1546. PubMed ID: 31752785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination coverage rates and predictors of HPV vaccination among eligible and non-eligible female adolescents at the Brazilian HPV vaccination public program.
    Faisal-Cury A; Levy RB; Tourinho MF; Grangeiro A; Eluf-Neto J
    BMC Public Health; 2020 Apr; 20(1):458. PubMed ID: 32252705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement of Parent's awareness, knowledge, perception, and acceptability of human papillomavirus vaccination after a structured-educational intervention.
    Sitaresmi MN; Rozanti NM; Simangunsong LB; Wahab A
    BMC Public Health; 2020 Dec; 20(1):1836. PubMed ID: 33256697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parents' and providers' attitudes toward school-located provision and school-entry requirements for HPV vaccines.
    Vercruysse J; Chigurupati NL; Fung L; Apte G; Pierre-Joseph N; Perkins RB
    Hum Vaccin Immunother; 2016 Jun; 12(6):1606-14. PubMed ID: 26934421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, controlled, pragmatic trial of an iPad-based, tailored messaging intervention to increase human papillomavirus vaccination among Latinos.
    Dempsey AF; Maertens J; Sevick C; Jimenez-Zambrano A; Juarez-Colunga E
    Hum Vaccin Immunother; 2019; 15(7-8):1577-1584. PubMed ID: 30689494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Provider and Parent Perspectives on Enhanced Communication Tools for Human Papillomavirus Vaccine-Hesitant Parents.
    Lockhart S; Dempsey AF; Pyrzanowski J; O'Leary ST; Barnard JG
    Acad Pediatr; 2018; 18(7):776-782. PubMed ID: 30177028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of a school-based educational intervention on HPV and HPV vaccine knowledge and willingness to be vaccinated among Chinese adolescents : a multi-center intervention follow-up study.
    Zhang X; Liu CR; Wang ZZ; Ren ZF; Feng XX; Ma W; Gao XH; Zhang R; Brown MD; Qiao YL; Geng Q; Li J
    Vaccine; 2020 Apr; 38(20):3665-3670. PubMed ID: 32245644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact and acceptability of self-consent procedures for the school-based human papillomavirus vaccine: a mixed-methods study protocol.
    Audrey S; Batista Ferrer H; Ferrie J; Evans K; Bell M; Yates J; Roderick M; MacLeod J; Hickman M
    BMJ Open; 2018 Mar; 8(3):e021321. PubMed ID: 29502095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Misinformation Drives Low Human Papillomavirus Vaccination Coverage in South African Girls Attending Private Schools.
    Milondzo T; Meyer JC; Dochez C; Burnett RJ
    Front Public Health; 2021; 9():598625. PubMed ID: 33681125
    [No Abstract]   [Full Text] [Related]  

  • 30. Short Message Service Reminders to Parents for Increasing Adolescent Human Papillomavirus Vaccination Rates in a Secondary School Vaccine Program: A Randomized Control Trial.
    Tull F; Borg K; Knott C; Beasley M; Halliday J; Faulkner N; Sutton K; Bragge P
    J Adolesc Health; 2019 Jul; 65(1):116-123. PubMed ID: 30879881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multilevel perspectives on school-based opportunities to improve HPV vaccination among medically underserved adolescents: Beyond school entry mandates.
    Shin MB; Sloan K; Baezconde-Garbanati L; Dang E; Garcia S; Palinkas LA; Unger JB; Willgerodt M; Crabtree BF; Tsui J
    Hum Vaccin Immunother; 2023 Aug; 19(2):2251815. PubMed ID: 37666253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Policy and socio-cultural differences between cantons in Switzerland with high and low adolescent vaccination coverage for hepatitis B and HPV.
    Masserey Spicher V; Weiss MG
    Vaccine; 2019 Dec; 37(52):7539-7546. PubMed ID: 31630937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016.
    Gallagher KE; Howard N; Kabakama S; Mounier-Jack S; Burchett HED; LaMontagne DS; Watson-Jones D
    Papillomavirus Res; 2017 Dec; 4():72-78. PubMed ID: 29179873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of one and two human papillomavirus (HPV) vaccine doses on community-level HPV prevalence in South African adolescent girls: study protocol and rationale for a pragmatic before-after design.
    Machalek D; Rees H; Chikandiwa A; Munthali R; Travill D; Mbulawa Z; Petoumenos K; Delany-Moretlwe S; Kaldor J;
    BMJ Open; 2022 Feb; 12(2):e059968. PubMed ID: 35144959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Community-based household assessment of human papillomavirus (HPV) vaccination coverage and acceptability - HPV vaccine demonstration program, Cambodia - 2017.
    Garon J; Wuddhika IV; Sreenivasan N; Wannemuehler K; Vutthikol Y; Chhorvann C; Loharikar A
    Vaccine; 2019 Feb; 37(9):1202-1208. PubMed ID: 30686637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of school-based educational interventions in middle adolescent populations (15-17yrs) on human papillomavirus (HPV) vaccination uptake and perceptions/knowledge of HPV and its associated cancers: A systematic review.
    Flood T; Wilson IM; Prue G; McLaughlin M; Hughes CM
    Prev Med; 2020 Oct; 139():106168. PubMed ID: 32603795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HPV vaccination coverage in three districts in Zimbabwe following national introduction of 0,12 month schedule among 10 to 14 year old girls.
    LaMontagne DS; Manangazira P; Marembo J; Chigodo C; Zvamashakwe C; Tshuma E; Marima E; Chindedza K; Ndlela E; Mooney J
    Vaccine; 2022 Mar; 40 Suppl 1():A58-A66. PubMed ID: 34275674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cross-sectional survey of parental attitudes towards Human papillomavirus vaccination exclusion categories in Brazil.
    Gattegno MV; Vertamatti MAF; Bednarczyk RA; Evans DP
    BMC Int Health Hum Rights; 2019 Feb; 19(1):6. PubMed ID: 30819169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lessons learnt during the national introduction of human papillomavirus (HPV) vaccination programmes in 6 African countries: Stakeholders' perspectives.
    Abdullahi LH; Hussey GD; Wiysonge CS; Kagina BM
    S Afr Med J; 2020 May; 110(6):525-531. PubMed ID: 32880566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calling the Shots? Adolescents' Influence on Human Papillomavirus Vaccine Decision-Making During Clinical Encounters.
    Fenton ATHR; Eun TJ; Clark JA; Perkins RB
    J Adolesc Health; 2020 Apr; 66(4):447-454. PubMed ID: 31974012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.